Defending psychiatry or defending the trivial effects of therapeutic interventions? A citation content analysis of an influential paper.

作者: I. A. Cristea , F. Naudet

DOI: 10.1017/S2045796017000750

关键词:

摘要: Aims Leucht et al. in 2012 described an overview of meta-analyses the efficacy medication psychiatry and general medicine, concluding that psychiatric drugs were not less efficacious than other drugs. Our goal was to explore dissemination this highly cited paper, which combined a thought provoking message with series caveats. Methods We conducted prospectively registered citation content analysis. All papers published before June 1st citing target paper independently rated by two investigators. The primary outcome coded dichotomously whether used justify small or modest effect observed for given treatment. Secondary outcomes regarded mentioning any caveats when point making (treatment effectiveness closely resembles others), type condition (psychiatric, medical both), specific disease, treatment category type. also extracted information about financial conflict interest (COI) declared industry support. analysis descriptive tabulating variables, numbers percentages where appropriate. Co-authorship networks constructed identify possible clusters authors. An exploratory univariate logistic regression relationship between each subset pre-specified secondary outcome. Results identified 135 records retrieved analysed 120. Sixty-three (53%) quoted al.'s therapy, 113 (94%) did mention Seventy-two (60%) claim medicine; 110 (91%) conditions. Forty-one (34%) it without pointing towards category, 28 (23%) antidepressants, 18 (15%) antipsychotics. Forty (33%) included data. COIs reported 55 (46%). Univariate multivariate regressions showed association quote justifying effects medicine. Conclusions evaluation revealed overwhelmingly uncritical reception seemed indicate beyond defending as discipline, served lend support credibility therapeutic myth: trivial mental health interventions, most often drugs, are be expected therefore accepted.Protocol registration: https://osf.io/9dqat/.

参考文章(27)
Nina A. Sayer, Siamak Noorbaloochi, Patricia A. Frazier, James W. Pennebaker, Robert J. Orazem, Paula P. Schnurr, Maureen Murdoch, Kathleen F. Carlson, Amy Gravely, Brett T. Litz, Randomized Controlled Trial of Online Expressive Writing to Address Readjustment Difficulties Among U.S. Afghanistan and Iraq War Veterans Journal of Traumatic Stress. ,vol. 28, pp. 381- 390 ,(2015) , 10.1002/JTS.22047
DR Coghill, S Fazel, JR Geddes, H Grunze, EA Holmes, O Howes, S Hudson, N Hunt, I Jones, IC Macmillan, H McAllister-Williams, DR Miklowitz, R Morriss, M Munafò, C Paton, BJ Sahakian, KEA Saunders, JMA Sinclair, D Taylor, E Vieta, AH Young, GM Goodwin, PM Haddad, IN Ferrier, JK Aronson, TRH Barnes, A Cipriani, Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology Journal of Psychopharmacology. ,vol. 30, pp. 495- 553 ,(2009) , 10.1177/0269881116636545
D. Taylor, A. Sparshatt, S. Varma, O. Olofinjana, Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies BMJ. ,vol. 348, pp. g1888- g1888 ,(2014) , 10.1136/BMJ.G1888
Olga Vaccaro, Maria Masulli, Enzo Bonora, Stefano Del Prato, Gabriele Riccardi, Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes The Lancet. ,vol. 384, pp. 1096- 1097 ,(2014) , 10.1016/S0140-6736(14)61672-X
Joanna Moncrieff, The creation of the concept of an antidepressant: an historical analysis. Social Science & Medicine. ,vol. 66, pp. 2346- 2355 ,(2008) , 10.1016/J.SOCSCIMED.2008.01.047
Stefan Leucht, Sandra Hierl, Werner Kissling, Markus Dold, John M. Davis, Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses British Journal of Psychiatry. ,vol. 200, pp. 97- 106 ,(2012) , 10.1192/BJP.BP.111.096594